AzTrials
AzTrials

Autism Spectrum DisordersNCT01780090

Handheld Technology for Speech Development in Students With Autism

A study testing iPad software in people with Autism Spectrum Disorders, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study will result in a software application compatible with the Apple iPad, iPhone and iPod Touch (hereafter termed "iOS devices") which addresses several aspects of prosodic deficits common in speakers with Autism Spectrum Disorders (ASDs) and other communication disorders, using a developmentally… Read more about this study

Who is it for?
Ages 4 to 19 years
Conditions the study is for
Autism Spectrum Disorders
What is being tested?
iPad software
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
Sep 2012to Jan 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • SLPs, in Connecticut Public Schools, who provide intervention to students with autism spectrum disorders.
  • Students, ages 4 - 19, who attend school in Connecticut and demonstrate prosodic difficulties secondary to a diagnosis of ASD.

Who cannot join

  • Students with concommitant genetic disorders

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale Child Study Center

    New Haven, Connecticut, 06510

Other trials in United States

About this study

Official title: Handheld Technology for Speech Development in Students With Autism Spectrum Disorders (ASDs)

The proposed study will result in a software application compatible with the Apple iPad, iPhone and iPod Touch (hereafter termed "iOS devices") which addresses several aspects of prosodic deficits common in speakers with Autism Spectrum Disorders (ASDs) and other communication disorders, using a developmentally appropriate, intuitive interface that requires little technical skill and which can be managed by educators and parents. The program will contain elements that aid in tracking and maintaining individual student progress records, and will be designed for use in the classroom, at home, and in other environments. This study's intended focus is on the feasibility and usability of the software application.

Being tested
iPad software
Keywords
autism, prosody, speech, autism spectrum disorder
Medical subject headings
Autism Spectrum Disorder, Autistic Disorder, Speech

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iPad softwareOther

    A specialized iPad application, entitled SpeechPrompts, has been developed to treat prosodic difficulties commonly seen in ASDs. SpeechPrompts provides the SLPs that work with students with ASDs an additional tool to treat prosody. The SpeechPrompts software offers visual support and biofeedback to change prosody. These two tools are not typically available for school-based SLPs.

Study groups in NCT01780090
Study groupRoleWhat they receive
iPad softwareExperimentalStudent participants will use specialized, iPad software under the direction of the SLP, 1 time a week over the course of 2 months.
Receives: Other: iPad software

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Learning of software

    Assessment of Outcome:

    Each speech-language pathologist (SLP) will complete a software training then take a post-training online assessment measuring software competency.

    Measured: 3 months

  2. Usability of software

    Assessment of Outcome:

    SLPs will complete satisfaction surveys and attend a focus group to obtain information regarding software usability.

    Measured: 3 months

Secondary outcomes (2)
  1. Student engagement in treatment

    Assessment of Outcome:

    SLPs will rate the student's engagement using a rating scale after each treatment session with the iPad and software.

    Measured: 3 months

  2. Software effectiveness

    Assessment of Outcome:

    SLPs will rate student participants' prosody before and after iPad treatment using a specialized rubric to measure changes in speech production.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2013 (estimated)
  2. Study startSep 2012
  3. Primary completionDec 2012
  4. Study completionJan 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01780090
Sponsor's protocol ID
1208010627
Other IDs
ED-IES-12-R-0007
Status last verified
Jan 2013
First submitted
28 Jan 2013
Last updated
30 Jan 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing iPad software in people with Autism Spectrum Disorders, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Learning of software (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in